What criteria is used to determine if a patient should start cholesterol-lowering medication?

The criteria for starting cholesterol-lowering medication primarily hinge on the patient's LDL (low-density lipoprotein) level and their overall risk for cardiovascular disease. This approach is based on well-established guidelines that recognize LDL cholesterol as a significant risk factor in the development of heart disease.

High levels of LDL cholesterol can lead to a buildup of cholesterol in the arteries, increasing the risk of atherosclerosis and ultimately cardiovascular events such as heart attacks and strokes. Therefore, a patient showing elevated LDL levels, in conjunction with assessments of their cardiovascular risk – which may include factors such as age, smoking status, blood pressure, presence of diabetes, and family history of heart disease – would be considered for medication.

While other options may include relevant factors in assessing cardiovascular health, they do not specifically focus on the dual importance of LDL levels and cardiovascular disease risk assessment, which are instrumental in making a decision about starting cholesterol-lowering therapy. Thus, the combination of these two criteria provides a clear and evidence-based framework for initiating treatment in patients.